VAM
BPMC

Visium Asset Management’s Blueprint Medicines BPMC Stock Holding History

Visium Asset Management’s Portfolio BPMC Stock Details BPMC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-10,250
Closed -$208K – 31
2016
Q2 		$208K Sell
10,250
-1,254,775
-99% -$22.8M 0.01% 317
2016
Q1 		$22.8M Buy
1,265,025
+245,025
+24% +$4.25M 0.39% 57
2015
Q4 		$26.9M Hold
1,020,000
– – 0.4% 45
2015
Q3 		$21.8M Buy
1,020,000
+75,000
+8% +$2.07M 0.3% 64
2015
Q2 		$25M Buy
+945,000
New +$27M 0.35% 50

Other funds holding BPMC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Visium Asset Management's BPMC Position: Q3 2016 in Review

Visium Asset Management sold out of Blueprint Medicines (BPMC) in Q3 2016, closing a stake of 10,250 shares — an estimated $208K sold.

Visium Asset Management first reported a position in BPMC in Q2 2015 and held it in 5 quarters. The position peaked at $26.9M in Q4 2015. 87 funds tracked by Wall St. Rank hold BPMC as of Q3 2016.

  • Visium Asset Management reported no remaining Blueprint Medicines position as of Q3 2016 after selling out during the quarter.
  • Visium Asset Management sold 10,250 Blueprint Medicines shares in Q3 2016, an estimated $208K.
  • Visium Asset Management first reported a position in Blueprint Medicines in Q2 2015 and held it in 5 quarters.
  • Visium Asset Management's Blueprint Medicines position peaked at $26.9M in Q4 2015.
  • 87 funds tracked by Wall St. Rank held Blueprint Medicines as of Q3 2016.

Based on Visium Asset Management's 13F filing for Q3 2016.